Imipramine blue: a novel NOX inhibitor as potent therapeutic agent to treat triple-negative breast cancers

被引：1
|
作者：
Rajamanickam, Subapriya [1 ]
Subbarayalu, Panneerdoss [1 ]
Timilsina, Santhosh [1 ]
Drake, Michael T. [1 ]
Zhao, Zhenze [1 ]
Chen, Hung I. Harry [1 ]
Chen, Yidong [1 ]
Arbiser, Jack L. [2 ]
Rao, Manjeet K. K. [1 ]
机构：
[1] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA
[2] Emory Univ, Sch Med, Atlanta, GA USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-1787
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1787
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Triple-negative breast cancers
    Narod, Steven A.
    Dent, Rebecca
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (10) : 1041 - 1043
  • [2] Novel treatment options for triple-negative breast cancers
    Hastak, Kedar
    Alli, Elizabeth
    Ford, James M.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3573S - 3573S
  • [3] Targeted EV to Deliver Chemotherapy to Treat Triple-Negative Breast Cancers
    Si, Yingnan
    Chen, Kai
    Ngo, Hanh Giai
    Guan, Jia Shiung
    Totoro, Angela
    Zhou, Zhuoxin
    Kim, Seulhee
    Kim, Taehyun
    Zhou, Lufang
    Liu, Xiaoguang
    [J]. PHARMACEUTICS, 2022, 14 (01)
  • [4] Protein arginine methyltransferase 5: A novel therapeutic target for triple-negative breast cancers
    Vinet, Mathilde
    Suresh, Samyuktha
    Maire, Virginie
    Monchecourt, Clarisse
    Nemati, Fariba
    Lesage, Laetitia
    Pierre, Fabienne
    Ye, Mengliang
    Lescure, Auriane
    Brisson, Amelie
    Meseure, Didier
    Nicolas, Andre
    Rigaill, Guillem
    Marangoni, Elisabetta
    Del Nery, Elaine
    Roman-Roman, Sergio
    Dubois, Thierry
    [J]. CANCER MEDICINE, 2019, 8 (05): : 2414 - 2428
  • [5] Tumor penetrating peptides inhibiting MYC as a potent targeted therapeutic strategy for triple-negative breast cancers
    Edina Wang
    Anabel Sorolla
    Paula T. Cunningham
    Heique M. Bogdawa
    Samuel Beck
    Emily Golden
    Robert E. Dewhurst
    Laura Florez
    Mark N. Cruickshank
    Katrin Hoffmann
    Richard M. Hopkins
    Jonghwan Kim
    Andrew J. Woo
    Paul M. Watt
    Pilar Blancafort
    [J]. Oncogene, 2019, 38 : 140 - 150
  • [6] Tumor penetrating peptides inhibiting MYC as a potent targeted therapeutic strategy for triple-negative breast cancers
    Wang, Edina
    Sorolla, Anabel
    Cunningham, Paula T.
    Bogdawa, Heique M.
    Beck, Samuel
    Golden, Emily
    Dewhurst, Robert E.
    Florez, Laura
    Cruickshank, Mark N.
    Hoffmann, Katrin
    Hopkins, Richard M.
    Kim, Jonghwan
    Woo, Andrew J.
    Watt, Paul M.
    Blancafort, Pilar
    [J]. ONCOGENE, 2019, 38 (01) : 140 - 150
  • [7] Therapeutic Strategies for Metastatic Triple-Negative Breast Cancers: From Negative to Positive
    Nandini, Dey
    Jennifer, Aske
    Pradip, De
    [J]. PHARMACEUTICALS, 2021, 14 (05)
  • [8] Therapeutic effects of TOPK inhibitor on triple-negative breast cancer
    Park, Jae-Hyun
    Miyamoto, Takashi
    Matsuo, Yo
    Nakamura, Yusuke
    [J]. CANCER RESEARCH, 2015, 75
  • [9] The Omics of Triple-Negative Breast Cancers
    Xu, Hong
    Eirew, Peter
    Mullaly, Sarah C.
    Aparicio, Samuel
    [J]. CLINICAL CHEMISTRY, 2014, 60 (01) : 122 - 133
  • [10] TTK: A novel target for radiosensitization in triple-negative breast cancers
    Chandler, Benjamin C.
    Moubadder, Leah
    Ritter, Cassie
    Niknafs, Yashar
    Olsen, Eric
    Cameron, Meleah
    Liu, Meilan
    Wilder-Romans, Kari
    Nyati, Shyam
    Brown, Powel
    Chinnaiyan, Arul
    Speers, Corey
    [J]. CANCER RESEARCH, 2018, 78 (13)
12345